Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-042414

BioPharmX Corp · BPMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 22, 2016
Accepted (ET)
Nov 30, 2016 · 6:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Nov 22, 2016P$04,375,000$0.00A9,499,615ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class A WarrantsF1,F2,F3,F4$0.35Nov 22, 2016P4,375,000A——Common Stock3,281,2504,375,000I

Explanation of responses

Remarks

ex99-1.txt, ex99-2.txt, ex99-3.txt, ex99-4.txt, ex99-5.txt